Skip to main content
Masimo Corporation (MASI)
NASDAQ: MASI · Real-Time Price · USD
175.45
+0.03 (0.02%)
At close: Mar 9, 2026, 4:00 PM EDT
175.21
-0.24 (-0.14%)
After-hours: Mar 9, 2026, 6:30 PM EDT

Masimo Revenue

In the fiscal year ending January 3, 2026, Masimo had annual revenue of $1.53B with 9.44% growth. Masimo had revenue of $412.50M in the quarter ending January 3, 2026, with 11.97% growth.

Revenue (ttm)
$1.53B
Revenue Growth
+9.44%
P/S Ratio
5.99
Revenue / Employee
$694,045
Employees
2,200
Market Cap
9.16B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jan 3, 20261.53B131.70M9.44%
Dec 28, 20241.40B119.70M9.38%
Dec 30, 20231.28B-760.30M-37.35%
Dec 31, 20222.04B796.60M64.28%
Jan 1, 20221.24B95.50M8.35%
Jan 2, 2021 Pro Pro Pro
Dec 28, 2019 Pro Pro Pro
Dec 29, 2018 Pro Pro Pro
Dec 30, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Zimmer Biomet Holdings 8.23B
Smith & Nephew 6.16B
Bruker 3.44B
Globus Medical 2.94B
Insulet 2.71B
Bio-Rad Laboratories 2.58B
Bio-Rad Laboratories 2.58B
Penumbra 1.40B
Revenue Rankings

MASI News

More News